Steps to Protect Lab Revenue Against Upcoming Reimbursement Cuts

For years, clinical laboratories have operated under the constant threat of annual reductions to reimbursements for the services they provide. However, with more Medicare rate reductions set to take effect at the start of 2025, the industry must band together to push back against PAMA and other legislative actions that threaten their ability to serve patients.

Please join us as we welcome Erin Morton and Meghan Riley, policy advocates for the National Independent Laboratory Association, to provide a detailed look at clinical lab cuts over time and how Congress can address this issue. Experts from our RCM Solutions team will also be joining the call to share their view of the current reimbursement landscape and offer actionable steps labs can take now to safeguard their revenue amidst these changes.

We'll cover:

-An overview of clinical lab reimbursement cuts in recent years and how this issue can be addressed by Congress.
-Other Medicare and private payer initiatives limiting lab payments.
-Steps labs can take to protect their revenue now.
-Action steps to bring attention to this issue and the importance of laboratory medicine.